Literature DB >> 28404669

Retinopathy of prematurity: screening and treatment in Costa Rica.

Ana Catalina Tabarez-Carvajal1, Milagro Montes-Cantillo1, Kelly H Unkrich2, Rupal H Trivedi2, Mae Millicent Winfrey Peterseim2.   

Abstract

AIM: To determine the recent demographic data, risk factors and results of retinopathy of prematurity (ROP) screening and treatment in Costa Rica.
METHODS: The medical records of all preterm infants meeting ROP screening criteria (≤34 weeks' gestational age (GA) or birth weight (BW) ≤1750g, and those determined at risk by neonatologists) in the national healthcare system, Costa Rica, January 2010-December 2014, were retrospectively reviewed. The numbers and percentages of infants with ROP, risk factors, percentage of patients treated and treatment outcomes were determined. Comparison is made with screening criteria and literature reports of ROP incidence in other countries.
RESULTS: The study population included 3018 preterm infants. Overall, 585 patients (585/3018, 19.4%) were found to have ROP. Of these, 15.4% (90 patients) required laser treatment, and 53% of those requiring treatment had BW <1000g. Five babies requiring treatment were ≥32 weeks' GA but with BW ≤1750g. Aggressive posterior disease was found in nine patients, and two infants of those screened (2/3018, 0.07%) suffered severe visual impairment during the 5-year study period.
CONCLUSION: We provide comprehensive data of ROP care in Costa Rica allowing assessment and comparison of screening criteria and protocol. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2017. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  Child health (paediatrics); Retina

Mesh:

Year:  2017        PMID: 28404669     DOI: 10.1136/bjophthalmol-2016-310005

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  3 in total

1.  Retinopathy of prematurity occurrence and evaluation of screening policy in a large tertiary Greek cohort.

Authors:  Asimina Mataftsi; Stella Moutzouri; Paraskevi Karagianni; Nikolaos Ziakas; Vasiliki Soubasi; Periklis Brazitikos; Anna-Bettina Haidich
Journal:  Int Ophthalmol       Date:  2019-10-22       Impact factor: 2.031

2.  Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units.

Authors:  Ahmet Yagmur Bas; Nihal Demirel; Esin Koc; Dilek Ulubas Isik; İbrahim Murat Hirfanoglu; Turan Tunc
Journal:  Br J Ophthalmol       Date:  2018-03-08       Impact factor: 4.638

Review 3.  Prevalence and risk factors of retinopathy of prematurity in Iran: a systematic review and meta-analysis.

Authors:  Milad Azami; Zahra Jaafari; Shoboo Rahmati; Afsar Dastjani Farahani; Gholamreza Badfar
Journal:  BMC Ophthalmol       Date:  2018-04-02       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.